Results for tag: "Polycythemia Drug"

Polycythemia is a hematological disorder characterized by an increase in the number of red blood cells in the body. It is treated with drugs that reduce the production of red blood cells, such as hydroxyurea, interferon-alpha, and anagrelide. These drugs are used to reduce the risk of thrombosis, which is a major complication of polycythemia. Other drugs used to treat polycythemia include phlebotomy, which is the removal of excess red blood cells from the body, and erythropoietin, which is a hormone that stimulates the production of red blood cells. The polycythemia drug market is a subset of the larger hematological drug market. It is composed of drugs used to treat polycythemia and its associated complications. These drugs are used to reduce the risk of thrombosis, reduce the number of red blood cells, and stimulate the production of red blood cells. Some companies in the polycythemia drug market include Novartis, Pfizer, Amgen, and Johnson & Johnson. Show Less Read more